← All stocks

AYTU BIOPHARMA, INC

AYTU No buying or selling

CIK 0001385818 #4961 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

8 insiders · 0 transactions

0.1×

Joshua R. Disbrow holds only 0.1 times base salary in stock. $114.85K of shares against $590.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Joshua R. Disbrow last reported holding, valued at $1.50, the price Common Stock was last bought or sold at on the open market here, on 9 Jun 2025.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Disbrow Joshua R.

Chief Executive Officer

—

237,203

2.21%

$355.80K

+231.3%

Disbrow Jarrett

Chief Business Officer

—

76,568

0.7134%

$114.85K

+498.4%

Selhorn Ryan J

Chief Financial Officer

—

74,743

0.6964%

$112.11K

+3,844%

PYSZCZYMUKA GREG

Chief Commercial Officer

—

56,102

0.5227%

$84.15K

+144.2%

DOCKERY CARL

Director

—

31,152

0.2902%

$46.73K

+222.8%

LIU VIVIAN H

Director

—

29,825

0.2779%

$44.74K

+258.3%

JAIN ABHINAV

Director

—

29,500

0.2748%

$44.25K

+268.8%

Donofrio John Jr.

Director

—

23,762

0.2214%

$35.64K

+950.5%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 16

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 302,295

History held since 2 Sep 2016